The gold standard of Nuclear Medicine is medically justified diagnosis or treatment supported by reliable radiopharmaceuticals, imaging systems, measurements, competent professionals and patient safety. The newest camera or a striking functional image cannot substitute for appropriate clinical purpose and controlled interpretation.
This 23-chapter root explains PET, SPECT, hybrid imaging, radioactivity and dosimetry, radiopharmaceutical stewardship, radiation protection, theranostics and the IAEA’s QUANUM quality framework. All four worked cases are fictional, with no patient-level treatment instructions.
Educational content only. Nuclear medicine is regulated healthcare; examinations, therapies and the handling of radioactive materials require qualified medical and specialist professionals.
50-second summary: trusted nuclear medicine is a whole clinical system
- Start with a justified medical question and competent clinical authority.
- Understand what radiopharmaceuticals and imaging instruments actually measure.
- Keep radionuclide, activity unit, time and patient identity connected.
- Distinguish SPECT, PET and the separate CT component of hybrid imaging.
- Optimise for useful clinical information under applicable protection standards.
- Control radiopharmacy, equipment, dosimetry and the entire service workflow.
- Audit discrepancies, records and outcomes using qualified professional review.
Primary references: IAEA QUANUM nuclear medicine audits, IAEA 2024 Hybrid Imaging conference and IAEA International Basic Safety Standards. Use the chapter index, four fictional cases, service diagnostic or specialist library.
Nuclear Medicine: 23 chapters
- Start with the clinical question and the information nuclear medicine offers
- Understand why a radiopharmaceutical combines chemistry and radioactivity
- Distinguish radionuclides, activity and absorbed dose
- Begin diagnostic exposure with professional justification
- Optimise the examination for clinically usable information
- Distinguish planar imaging from tomographic methods
- Understand SPECT as measured data plus reconstruction
- Understand PET without treating its images as directly visible physiology
- Interpret PET/CT and SPECT/CT as combined systems
- Recognise time, activity and decay correction in quantitative work
- Make detector calibration and image quality assurance routine
- Preserve radiopharmaceutical quality and supply continuity
- Separate patient, worker and public radiation protection
- Understand radionuclide therapy as a specialised medical pathway
- Treat patient dosimetry as a measurement and modelling responsibility
- Explain theranostics without promising that pairing guarantees success
- Use audits, incident learning and digital controls to sustain quality
- Worked case: an activity record loses its time reference
- Worked case: hybrid images look aligned but are not
- Worked case: a low typical dose metric hides an inadequate study
- Worked case: an equipment check passes while a workflow fails
- Nuclear medicine diagnostic: examine the full patient and measurement chain
- The Nuclear Medicine specialist library and frequently asked questions
CHAPTER 1 OF 23 · Clinical purpose and radiopharmaceutical science
1. Start with the clinical question and the information nuclear medicine offers
Nuclear medicine uses radiopharmaceuticals and specialised measurement systems for diagnostic imaging and certain treatments. Unlike imaging based only on anatomy, many nuclear medicine examinations reveal aspects of physiological or molecular function through the distribution of a radioactive tracer. The gold standard is not the most detailed image or newest scanner. It is a clinically justified service that provides useful information or therapy while protecting people and documenting the evidence.
The International Atomic Energy Agency’s 2024 conference on hybrid imaging addresses the complementary roles of PET–CT, SPECT–CT, radiopharmaceutical therapy, dosimetry and quality management. These fields require qualified medical practitioners, technologists, physicists and pharmaceutical specialists. A technical explanation is not authorisation to perform a procedure or interpret a person’s scan.
Begin with what the responsible clinician needs to know. Is the question about tissue function, location of a particular process, treatment selection or monitoring under an approved care pathway? Different imaging methods and tests answer different questions, and the appropriate choice depends on the clinical circumstances rather than the reputation of one machine.
CHAPTER 2 OF 23 · Clinical purpose and radiopharmaceutical science
2. Understand why a radiopharmaceutical combines chemistry and radioactivity
A radiopharmaceutical is a pharmaceutical preparation containing a radionuclide. Its properties can influence where the substance goes, how it interacts with the body and what radiation a detector observes. The relevant chemical, biological and radioactive properties must all be understood within the intended diagnostic or therapeutic use. The same radionuclide associated with a different molecule may not have the same distribution or application.
Radiopharmaceutical preparation, quality assurance, identity, activity measurement and safe supply require qualified staff and regulated systems. An attractive chemical diagram cannot establish that a product is suitable for a patient, and a correct radioactivity measurement cannot substitute for assurance of pharmaceutical quality.
The IAEA’s QUANUM nuclear medicine quality-audit resource recognises radiopharmacy, clinical practice, physics and radiation protection as connected parts of one quality-management system. This article explains their relationship rather than providing preparation or administration instructions.
CHAPTER 3 OF 23 · Clinical purpose and radiopharmaceutical science
3. Distinguish radionuclides, activity and absorbed dose
Radionuclides are unstable atomic nuclei that transform through radioactive processes. Activity, expressed in becquerels (Bq), counts nuclear transformations per second. Absorbed dose, expressed in grays (Gy), concerns energy deposited per unit mass. Radiation-protection quantities expressed in sieverts (Sv) have another specified purpose. These cannot be exchanged merely because they all appear in discussions of nuclear medicine.
An instrument reporting activity in a sample does not directly report every organ’s absorbed dose or a person’s clinical risk. Interpretation depends on radionuclide, time, distribution, physical processes and the quantity’s intended meaning. Decimal precision cannot resolve missing unit or timing context.
Nuclear Physics and Metrology explain the measurement foundation. Patients benefit when professionals use accurate language and do not reduce important clinical decisions to a generic statement that ‘radiation was measured’.
CHAPTER 4 OF 23 · Clinical purpose and radiopharmaceutical science
4. Begin diagnostic exposure with professional justification
Medical exposure to ionising radiation can provide significant diagnostic or therapeutic benefit, but it must be appropriate for the individual and intended medical purpose. Justification asks whether the expected benefit supports the particular examination or treatment under the relevant clinical pathway. It is distinct from making the exposure as low as possible after deciding that the procedure should occur.
The IAEA’s International Basic Safety Standards distinguish patient medical exposure, occupational exposure and public protection and require quality assurance. Not every radiation-protection limit applies identically to a medically indicated patient procedure.
Qualified radiological medical practitioners assess the medical purpose, with physicists and other specialists supporting safe implementation. Educational readers should not interpret the presence of radiation as proof that a procedure is always inappropriate or assume that every technologically possible test is necessary.
CHAPTER 5 OF 23 · Clinical purpose and radiopharmaceutical science
5. Optimise the examination for clinically usable information
After an examination is justified, optimisation seeks the information needed for the clinical task with appropriate protection. An imaging system should not automatically be praised for the smallest output if that change degrades necessary information or causes repeat examination. Nor does greater activity or repeated scanning necessarily produce a better clinical answer.
Evaluate the intended target, representative patient and equipment conditions within the facility’s professional protocols. Imaging performance, radiation-related quantities, expected study duration and patient circumstances may all be relevant. Actual settings and procedures belong to trained personnel applying approved guidelines, not to a general webpage.
The IAEA radiation safety framework emphasises quality assurance and the use of appropriate diagnostic reference levels where established. Such reference levels support review of typical practice and should not be described as universal dose limits for individual patients. Reliable optimisation connects a physical measure with clinical usefulness.
CHAPTER 6 OF 23 · PET, SPECT and quantitative images
6. Distinguish planar imaging from tomographic methods
A gamma camera can detect emissions from suitable radiopharmaceuticals and produce images related to tracer distribution. Planar scintigraphy provides a projection-like view, while tomographic methods can construct representations of spatial distribution from multiple observations. These approaches have different advantages, limitations and reconstruction requirements.
A planar image does not contain all the spatial information available in a suitably performed tomographic study, but that does not make it useless. The appropriate technique depends on the clinical purpose and equipment. Conversely, a more complex modality is not automatically justified for every case.
Explain what the detector measured, how the image was formed and which interpretation requires clinical expertise. A picture showing tracer concentration is not a standalone pathological diagnosis. The Imaging Science root examines reconstruction and the limits of turning measured signals into useful representations.
CHAPTER 7 OF 23 · PET, SPECT and quantitative images
7. Understand SPECT as measured data plus reconstruction
Single photon emission computed tomography, or SPECT, uses observations from multiple angles to reconstruct a three-dimensional representation of tracer distribution. Results depend on detectors, calibration, acquisition, corrections and reconstruction assumptions. Apparent changes in an image can reflect biological differences, measurement limitations or processing methods.
Clinicians and medical physicists evaluate performance through relevant quality assurance, while technologists contribute safe acquisition and workflow expertise. A reconstructed hotspot cannot be interpreted without the radiopharmaceutical, examination purpose and anatomical context. Images may support useful findings without providing definitive answers in isolation.
The IAEA’s quality resources for nuclear medicine cover gamma cameras and SPECT systems among other technologies. A good educational comparison asks what was actually detected and how the image’s processing could affect interpretation, rather than simply ranking modalities by visual sharpness.
CHAPTER 8 OF 23 · PET, SPECT and quantitative images
8. Understand PET without treating its images as directly visible physiology
Positron emission tomography, or PET, measures signals associated with positron-emitting radiopharmaceuticals and uses computational reconstruction to represent tracer distribution. Image characteristics depend on radionuclide, biological distribution, detector and reconstruction performance. A bright image region may require careful clinical interpretation rather than automatic classification as one particular disease.
Different radiopharmaceuticals target different questions, and a result from one may not have the same meaning as another. Images can also change with physiological state, timing and procedure-specific factors. Nuclear medicine specialists must integrate the observation with the patient and intended application.
High-quality PET is more than a technically impressive scanner. It requires validated equipment, suitable radiopharmaceuticals, professional protocols, reliable data and meaningful reporting. The quality of an image should be judged against its purpose rather than its promotional appearance.
CHAPTER 9 OF 23 · PET, SPECT and quantitative images
9. Interpret PET/CT and SPECT/CT as combined systems
Hybrid imaging can combine functional information from nuclear medicine with anatomical information from computed tomography. PET/CT and SPECT/CT offer important clinical possibilities, but the modalities have different physical origins and safety considerations. The CT component uses x-rays, while the nuclear medicine component involves emissions associated with radiopharmaceuticals.
Registration between image datasets is essential when location matters. Patient movement, geometric calibration and software transformations can affect whether an area of apparent tracer activity aligns with the intended anatomy. A fused image may look natural to the viewer while concealing a mismatch that requires professional review.
The IAEA’s IPET 2024 conference highlighted hybrid imaging, clinical indications, physics, quality management and patient protection. The quality system must evaluate the whole composite examination, not assume two individually sound devices produce a correct result when connected.
CHAPTER 10 OF 23 · PET, SPECT and quantitative images
10. Recognise time, activity and decay correction in quantitative work
Radioactive activity changes over time according to the radionuclide’s physical decay properties. An activity value without the relevant radionuclide, unit and reference time may be ambiguous. Nuclear medicine workflows may move data among instruments, software systems and reports, creating opportunities to lose the information required to compare values correctly.
Quantification can be affected by biological distribution, imaging timing and equipment correction methods, as well as physical decay. A value from an early measurement should not automatically be compared with another measured later as though the contexts were identical. Data handling needs both numerical precision and semantic integrity.
The correct way to improve confidence is to preserve what each quantity means and who verified it. This educational article provides no radioactivity conversion instructions for clinical use; such calculations and decisions belong to qualified professionals under approved protocols.
CHAPTER 11 OF 23 · PET, SPECT and quantitative images
11. Make detector calibration and image quality assurance routine
Gamma cameras, PET scanners, activity meters and associated measurement systems have performance characteristics that can change with time, software or maintenance. Acceptance testing, commissioning and routine quality-control checks serve different functions. A successful start-up screen does not prove that a device remains appropriately calibrated for every clinical application.
The IAEA’s nuclear medicine quality-audit programme emphasises continuous service improvement, appropriate equipment checks and collaboration among professional groups. Clinical teams should define which evidence is needed to release equipment for its intended use and how unexpected discrepancies are escalated.
Document device identity, important configuration, measurements, relevant references, corrective actions and approval. A reading within an expected range in one test does not independently verify all downstream image or clinical interfaces. The gold standard connects checks to plausible failures and to patient care.
CHAPTER 12 OF 23 · Radiation safety, therapy and service quality
12. Preserve radiopharmaceutical quality and supply continuity
Radiopharmacy involves the professional preparation, supply and quality management of radioactive pharmaceutical products. Reliability depends on suitable products, authorised staff, traceability and compliance with relevant pharmaceutical and radiation standards. A supply problem can delay a clinically useful examination even when the scanner itself operates perfectly.
Radiopharmaceutical properties and time-dependent activity can also affect coordination among production, transport, imaging appointments and reporting. A hospital’s schedule and supply chain form part of the patient journey, not merely logistical background. Shortages may require authorised clinical decisions rather than improvised substitutions.
A good service records relevant product identity, quality verification, handling and changes under its lawful system. This article deliberately omits preparation, synthesis and administration instructions. Educational understanding should reinforce professional safeguards, not enable unqualified handling of radioactive materials.
CHAPTER 13 OF 23 · Radiation safety, therapy and service quality
13. Separate patient, worker and public radiation protection
Patients receiving appropriately justified medical procedures, workers handling radioactive materials and members of the public have different protection circumstances under relevant radiation-safety frameworks. Treating all three as if they share one universal exposure rule can produce incorrect explanations and decisions. Facilities must meet applicable rules for controlled areas, shielding, monitoring and other safeguards.
The IAEA International Basic Safety Standards specify distinct medical-exposure, occupational and public protection responsibilities. National regulatory requirements also govern practice and cannot be replaced by a global educational summary.
Staff and patient communication should explain the relevant purpose without fear-based oversimplification. Institutions need competent radiation protection and clear escalation. The goal is a justified clinical benefit reached through properly controlled operations, with attention to other people who may be affected.
CHAPTER 14 OF 23 · Radiation safety, therapy and service quality
14. Understand radionuclide therapy as a specialised medical pathway
Some radiopharmaceuticals are used therapeutically rather than only for diagnostic imaging. Their intent is to deliver radiation effects to defined biological targets under an authorised clinical plan. This is different from diagnostic optimisation, where the aim is sufficient information with proportionate exposure. A universal rule that all medical doses should be as small as possible would misunderstand therapeutic purpose.
Treatment selection, product suitability, activity, dosimetry and follow-up require appropriately qualified specialists working under current clinical and radiation safety requirements. This guide supplies no selection criteria, treatment doses or administration procedure for individual patients.
Scientific advances can make certain therapies promising, but availability, supporting evidence and safety requirements depend on the treatment and jurisdiction. The IAEA’s nuclear medicine quality and radiation-protection programmes address the broader systems that must surround clinical use.
CHAPTER 15 OF 23 · Radiation safety, therapy and service quality
15. Treat patient dosimetry as a measurement and modelling responsibility
Dosimetry estimates or measures radiation energy deposited in defined tissues and depends on both physical and biological assumptions. In nuclear medicine, radionuclide distribution and retention can vary among patients and over time. The absorbed dose to a particular organ cannot always be inferred directly from a displayed activity value.
Individualised dosimetry can require imaging, calibration, modelling and suitable uncertainty analysis under specialised professional oversight. The IAEA 2025 technical-meeting summary on radiation protection in modern nuclear medicine identifies continuing challenges for dosimetry, newer therapies and regulatory guidance. Those challenges should be presented honestly rather than concealed behind an elegant calculation.
Measurement confidence matters, but the final decision also depends on clinical context. A professional team should understand what each reported quantity supports and where the model’s limits could affect care.
CHAPTER 16 OF 23 · Radiation safety, therapy and service quality
16. Explain theranostics without promising that pairing guarantees success
Theranostics refers to approaches that connect diagnostic and therapeutic methods, sometimes through related molecular targeting. The idea can be powerful when evidence supports an intended patient group and a specific treatment pathway. However, detecting a target on imaging does not automatically mean a corresponding therapy will work or be safe for every patient.
Clinical evaluation considers target expression, disease context, appropriate indications, practical access, treatment effects and uncertainty. The IAEA’s 2024 hybrid imaging conference included theranostic applications and evidence-based discussion of therapies. Early research and established treatment must not be conflated.
Molecular Medicine explains how molecular results can inform clinical questions, while Medical Physics covers measurement and technology assurance. The Gold Standard insists on both, alongside qualified medical decisions.
CHAPTER 17 OF 23 · Radiation safety, therapy and service quality
17. Use audits, incident learning and digital controls to sustain quality
Nuclear medicine services need more than one successful commissioning report. Clinical practice, radiopharmacy, equipment, patient records, staff training, radiation protection and follow-up must remain dependable as conditions change. A quality-management audit is useful when it reveals risks and leads to reviewable improvement, not merely a favourable aggregate score.
IAEA’s Quality Management Audits in Nuclear Medicine Practices (QUANUM) promotes systematic, patient-oriented assessment across multidisciplinary services. The 2021 QUANUM 3.0 tool provides an updated audit framework. Digital data, software versions and external services create further dependencies that require appropriate security and traceability.
Records should distinguish original observations, interpretations, corrections and authorised decisions. Where AI or automated image-processing tools are used, meaningful validation and qualified oversight are necessary. A quality programme does not promise perfection; it knows how to detect and correct consequential failure.
CHAPTER 18 OF 23 · Fictional patient-safety cases
18. Worked case: an activity record loses its time reference
A fictional nuclear medicine service exports a radioactivity measurement to another application. The receiving system retains the number but not the time to which the value refers. Another staff member compares it directly with measurements made later and reports an apparent disagreement.
The records may both be genuine while the comparison is invalid. Qualified staff should use approved processes to establish source identity, units and reference times, then assess whether any clinical record or decision was affected. Do not guess the missing time or insert an invented correction to make a chart agree.
The lesson is that measured quantity, timing and context must travel together. A complete data-transfer quality system includes checking the meaning of fields, not only whether a number reached the destination.
CHAPTER 19 OF 23 · Fictional patient-safety cases
19. Worked case: hybrid images look aligned but are not
A fictional hybrid imaging service updates a reconstruction or registration component. Images remain visually attractive, yet an independent quality check suggests that a small geometrical mismatch may affect interpretation in some cases. A manager proposes continuing unchanged because the images look normal at first glance.
Use authorised professional escalation and quality procedures to investigate the affected interface, physical checks, software version and clinical significance. This educational case intentionally omits numeric tolerances and operational correction steps. A pleasing composite image does not prove that all spatial transformations remained correct.
After competent resolution, document the evidence and return-to-service decision. The case illustrates why imaging quality includes data integrity and geometry as well as visual contrast.
CHAPTER 20 OF 23 · Fictional patient-safety cases
20. Worked case: a low typical dose metric hides an inadequate study
A fictional department modifies a diagnostic protocol and observes a lower typical dose-related indicator. It celebrates the number without reviewing whether the studies still answer the intended clinical questions. Clinicians later note more incomplete or non-diagnostic examinations for a particular task.
A proper professional review considers image usefulness, patient group, acquisition method, measured quantities, repeats and relevant uncertainties. The appropriate response is not simply to increase or reduce exposure based on a public rule. The aim is a justified examination optimised for meaningful information under competent clinical governance.
The learning point is that a favourable physical metric and a favourable patient outcome must be evaluated separately before being called a success.
CHAPTER 21 OF 23 · Fictional patient-safety cases
21. Worked case: an equipment check passes while a workflow fails
A fictional nuclear medicine facility records that its imaging equipment passed routine quality-control checks. On a busy day, a patient and radiopharmaceutical record are temporarily mismatched between the booking and reporting systems. The scanner’s physical performance remains correct, but the end-to-end clinical process is unreliable.
The team should follow its authorised patient safety and incident procedures, preserve relevant records and review the interfaces that allowed ambiguity. Physical quality assurance is necessary but cannot establish correct identity or successful communication throughout the service.
Use the event to improve identity checks, information handovers and staff training under appropriate standards. The Gold Standard evaluates the entire patient journey, not merely a machine’s technical test results.
CHAPTER 22 OF 23 · Diagnostics and learning routes
22. Nuclear medicine diagnostic: examine the full patient and measurement chain
Ask why an examination or treatment is being considered and who has clinical authority. Which radiopharmaceutical, biological purpose and measurement quantities are involved? Are the specimen or product identity, activity, reference time and equipment configuration reliably recorded? Have justification, quality and relevant radiation-protection responsibilities been considered through approved professional processes?
Then examine image formation and interpretation. Are acquisition and reconstruction suitable for the clinical purpose? Are hybrid images correctly registered? Does the physical metric support the claim being made, and what uncertainty remains? Are software changes and patient records controlled? For therapy, are professional dosimetry and follow-up arrangements appropriately governed?
Finally ask how the service responds to a discrepancy, who can stop unsafe use and which evidence supports a return to care. A good diagnostic locates one consequential missing link and an accountable qualified next action. It does not give untrained readers permission to adjust equipment or provide treatment.
CHAPTER 23 OF 23 · Diagnostics and learning routes
23. The Nuclear Medicine specialist library and frequently asked questions
Begin with Medicine, Medical Physics, Nuclear Physics, Radiation and Imaging Science. Continue through Metrology, Scientific Instrumentation, Medical Ethics and Medical Imaging Engineering for more specialised questions.
Does nuclear medicine mean only nuclear power? No; it uses radiopharmaceuticals in medical imaging and treatment. Are PET and SPECT identical? No; they measure different emissions through different systems. Does activity in Bq equal organ dose? No. Does every tracer finding imply disease? No, clinical context matters. Trace a fictional measurement from purpose to interpretation using the immutable Clementi Mathematics teaching reference: identify the unstable relationship and test transfer. Continue to Learning That Transfers Into Life and the Gold Standard hub.
Official technical guidance and clinical limitations
- IAEA: Quality Management Audits in Nuclear Medicine (QUANUM).
- IAEA: QUANUM 3.0, Third Edition (2021).
- IAEA: International Conference on Hybrid Imaging and Theranostics (2024).
- IAEA: International Basic Safety Standards for medical exposures.
- IAEA: Nuclear Medicine for Diagnosis and Treatment.
Actual nuclear medicine decisions, facilities, patient dosimetry, radiopharmaceutical preparation and radiation protection require current local regulatory rules, approved procedures and qualified clinical professionals. No fictional example describes real patients or provides a treatment protocol.